Global Conjugate Vaccines Market Professional Survey Report 2019

SKU ID :QYR-14568782 | Published Date: 03-Oct-2019 | No. of pages: 104
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.
This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.
The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.

The global Conjugate Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Conjugate Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Conjugate Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Conjugate Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Conjugate Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
By type
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
By disease indication
Pneumococcal
Influenza
Diphtheria Tetanus and Pertussis (DTP)
Meningococcal
Others
By pathogen type
Bacterial Conjugate Vaccine
Viral Conjugate Vaccine
Combination (Viral and Bacterial) Conjugate Vaccine

Segment by Application
Pediatrics
Adults
  • PRICE
  • $3500
    $7000
    Buy Now

Our Clients